Leading, funding and structuring research

Leading research

ANRS MIE pursues an active research coordination policy to support project creation and development, and strengthen collaboration between researchers, institutions and patient associations. These committees bring together French and international experts from all research institutions: national bodies, universities, university hospitals/centres, as well as institutions committed to the “One Health” approach.

ANRS MIE brings together members of the scientific community within various groups of people: coordinated actions, working groups and subgroups, networks, task forces, etc. The aim is to promote exchanges between researchers from different institutions or specialties and representatives of patient associations.

Patient associations are fully embedded in the construction of research projects supported by the agency. Today, more than 20 patient associations actively collaborate with researchers in
scientific facilitation groups.

These scientific facilitation groups help to stimulate reflection on specific topics, encourage research collaboration and the design of innovative projects, highlight priority areas for research or, on the contrary, areas that receive less attention and yet are necessary.

Conferences, international congresses, and scientific days

International conferences and scientific days follow the same logic of fostering research communities and disseminating research findings. ANRS MIE also contributes to research coordination by supporting conferences through its conference and publications call for proposals. The agency actively participates in international congresses and organizes its own scientific events, such as its annual meeting: the ANRS MIE Scientific Days.

Structuring research

To support the structuring of research on infectious diseases, in France and internationally, ANRS MIE funds, coordinates and supports reference networks, cohorts and platforms designed to be both sustainable and responsive in times of crisis.

Its actions include:

• • the financing and management of a dense network of hospital-based clinical research sites in France, supported by 80 clinical and biological study monitors, as well as methodology and management centres (“CMG”);
  • the financing and coordination of an international network of virology and clinical pharmacology, mobilising several dozen laboratories in France and abroad;
  • the financing and support for national and international cohorts covering various pathologies: HIV, hepatitis, tuberculosis, dengue fever, chikungunya, Lassa fever, etc.;
  • the coordination of three major infrastructures under the MIE Acceleration Strategy:
    – I-REIVAC for vaccinology in partnership with AP-HP (Greater Paris University Hospitals);
    – OPEN-ReMIE for therapeutic clinical research with Hospices Civils de Lyon;
    – EMERGEN for genomic monitoring with Santé publique France (French Public Health Agency) and Anses.